Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
NEW YORK (Reuters Health) – Office-based endometrial ablation for menorrhagia is equally effective with thermal balloon ablation or bipolar radiofrequency, U.K. researchers say. Six months after randomization and…
NEW YORK (Reuters Health) – Menses and ovulation are more likely to resume spontaneously after chemotherapy if women also receive a gonadotropin-releasing hormone (GnRH) analog – but pregnancy…
NEW YORK (Reuters Health) – Noninvasive uterine electromyography (EMG) identifies true preterm labor more accurately than clinical methods now in use, new research shows. “It can therefore identify…
NEW YORK (Reuters Health) – While elevated levels of anticardiolipin antibodies are associated with preeclampsia, measuring levels of anticardiolipin antibodies cannot be used to predict risk of preeclampsia…
NEW YORK (Reuters Health) – Over time, cervical intraepithelial neoplasia (CIN) grade 2 eventually resolves spontaneously in about two-thirds of adolescent and young adult women, according to findings…
NEW YORK (Reuters Health) – Ultrasound-guided high-intensity focused ultrasound (HIFU) ablation and the levonorgestrel intrauterine system (LNG-IUS) offer less invasive options for treating women with symptomatic adenomyosis, according…
NEW YORK (Reuters Health) – Routine screening for coagulation abnormalities before oocyte retrieval for in vitro fertilization (IVF) is costly and not clinically effective, researchers from Israel found…
NEW YORK (Reuters Health) – Magnetic resonance imaging of ovarian tumors is useful in predicting whether the lesion is malignant or benign, thereby helping to guide the therapeutic…
NEW YORK (Reuters Health) – The likelihood that a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive breast cancer on final…
NEW YORK (Reuters Health) – A selective with antiprogestin effects, CDB-2914, reduces uterine fibroid size and bleeding, and improves quality of life in affected women, according to a…
